Marco van Ham Cellular Proteome Research Helmholtz Centre for Infection Research Biography Publications Institution JoVE Articles Marco van Ham Marco van Ham is a senior scientist at the Cellular Proteome Resarch Group from Prof. Lothar Jänsch at the Helmholtz Centre for Infection Research in Braunschweig / Germany. He received his undergraduate and a Ph.D. from the Medical University of Nijmegen / the Netherlands.Marco van Ham is trained as a cell biologist with a focus on signalling pathways (tyrosine kinases and phosphatases) and microtubule dynamics (tubulin post-transational modifications). As a PostDoc (Medical University Rotterdam / the Netherlands), Marco van Ham, studied microtubule dynamics on a single cell level, using both cell lines as well as primary neuronal cells. In his recent position as senior scientist (HZI, Braunschweig / Germany), he now is mainly involved in spatial ex vivo recognition of host / pathogen interacions using high resolution mass spectromety and laser dissection microscopy. Publications Immune Monitoring of Human Mucosal-Associated Invariant T Cells by Quantitative Proteomics Methods in Molecular Biology (Clifton, N.J.). Month, 2020 | Pubmed ID: 31792825 ADAP Promotes Degranulation and Migration of NK Cells Primed During Infection in Mice Frontiers in Immunology. Month, 2019 | Pubmed ID: 32038647 Chronic Toxoplasma Infection is Associated with Distinct Alterations in the Synaptic Protein Composition Journal of Neuroinflammation. Aug, 2018 | Pubmed ID: 30068357 TCR Signalling Network Organization at the Immunological Synapses of Murine Regulatory T Cells European Journal of Immunology. 12, 2017 | Pubmed ID: 28833060 Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions Frontiers in Immunology. Month, 2013 | Pubmed ID: 23508354 Proteome Analysis of Distinct Developmental Stages of Human Natural Killer (NK) Cells Molecular & Cellular Proteomics : MCP. May, 2013 | Pubmed ID: 23315794 Conjugación química de un anticuerpo purificado dirigido por DEC-205 con proteína de longitud completa para atacar células dendríticas de ratón in vitro e in vivo Julia Volckmar1,2, Laura Knop1,2,3, Tatjana Hirsch1, Sarah Frentzel1,2, Christian Erck4, Marco van Ham4, Sabine Stegemann-Koniszewski*1,2,5, Dunja Bruder*1,2 1Immune Regulation Group, Helmholtz Centre for Infection Research, 2Infection Immunology Group, Institute of Medical Microbiology, Infection Prevention and Control, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 3Institute for Molecular and Clinical Immunology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 4Cellular Proteome Research, Helmholtz Centre for Infection Research, 5Experimental Pneumology, University Hospital of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg JoVE 62018 Cancer Research
Conjugación química de un anticuerpo purificado dirigido por DEC-205 con proteína de longitud completa para atacar células dendríticas de ratón in vitro e in vivo Julia Volckmar1,2, Laura Knop1,2,3, Tatjana Hirsch1, Sarah Frentzel1,2, Christian Erck4, Marco van Ham4, Sabine Stegemann-Koniszewski*1,2,5, Dunja Bruder*1,2 1Immune Regulation Group, Helmholtz Centre for Infection Research, 2Infection Immunology Group, Institute of Medical Microbiology, Infection Prevention and Control, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 3Institute for Molecular and Clinical Immunology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, 4Cellular Proteome Research, Helmholtz Centre for Infection Research, 5Experimental Pneumology, University Hospital of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg JoVE 62018 Cancer Research
